Note: The Prescribing Information pools its eight randomized, controlled trials across patients with CRPC (N = 3651), mCSPC (N = 754), and nmCSPC with high-risk BCR (N = 707).
Can Xtandi cause PRES (posterior reversible encephalopathy syndrome)?
Note: The Prescribing Information pools its eight randomized, controlled trials across patients with CRPC (N = 3651), mCSPC (N = 754), and nmCSPC with high-risk BCR (N = 707).
Does Xtandi increase the risk of ischemic heart disease?
Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.
Does Xtandi increase the risk of falls and fractures?
Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.
Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.
Note: The five placebo-controlled trials in this pooled statement include trials in castration-sensitive prostate cancer (ARCHES and EMBARK) as well as CRPC (AFFIRM, PROSPER, and PREVAIL).
Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, placebo Grade 1-4, and placebo Grade 3-4 percentages, in that order, as in the table header.
What side effects have been reported with Xtandi since approval?